Clinical Trial Update: ULTRA LONG: BioFreedom Ultra [NA]

View source ↗

Summary

Clinical trial update: ULTRA LONG: BioFreedom Ultra, sponsored by Biosensors Europe SA, remains active but not recruiting. The study investigates BioFreedom Ult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BioFreedom Ultra

Snippet

Sponsor: Biosensors Europe SA | Conditions: Coronary Artery Disease, High Bleeding Risk Patients | NA | Status: ACTIVE_NOT_RECRUITING